权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis

甘露糖代谢作为肝星状细胞活化和纤维化的调节剂

基本信息

批准号：
10731232
负责人：
Jaime C Chu
金额：
$ 9.94万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-01-01 至 2024-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10731232
关键词：
Address Apoptosis Attenuated Automobile Driving Biology Catabolism Cell Death Cell Proliferation Cells Cellular biology Child Childhood Cicatrix Cirrhosis Clinical Congenital Disorders Data Diabetes Mellitus Disease Dose Enzymes Ethanol Exposure to Fibrosis Genetic Goals Hepatic Stellate Cell Hepatitis B Virus Hepatocyte Hepatology Human In Vitro Isomerase Link Liver Liver Failure Liver Fibrosis Liver diseases Malignant Neoplasms Malignant neoplasm of liver Mannose Mediating Mediator Medical Metabolic Metabolic Pathway Metabolism Minor Modeling Mutation Obesity Pathway interactions Phenotype Public Health Rattus Regulation Rodent Rodent Model Role Supplementation Testing Therapeutic Thioacetamide Vitamin A Zebrafish antifibrotic treatment attenuation cancer cell cell type chronic liver disease cohort drug discovery efficacy evaluation fibrogenesis glycosylation in vivo inorganic phosphate liver metabolism liver transplantation mutant new therapeutic target non-alcoholic fatty liver disease novel prevent response restoration sugar

项目摘要

PROJECT SUMMARY Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis This proposal addresses the critical unmet need for effective anti-fibrotic therapies by elucidating an unexplored pathway regulating activation of the hepatic stellate cell (HSC), a resident perisinusoidal cell type that stores vitamin A in normal liver. However, among potential mechanisms driving HSC plasticity, sugar metabolism pathways have been largely overlooked. The role of mannose metabolism in HSC biology has not yet been examined, but recent high-impact studies, including ours (Shtraizent and DeRossi et al., eLife 2017), implicate mannose as a mediator of obesity, diabetes, and cancer. Mannose phosphate isomerase (MPI) is the key enzyme involved in catabolism of mannose; MPI mutation in humans leads to a congenital disorder of N- glycosylation characterized by early and progressive liver fibrosis in children. Our data and these clinical observations stimulated us to explore how the loss of MPI in this pediatric disorder leads to liver fibrosis. Our exciting data find that: 1) MPI is decreased during HSC activation and fibrosis in rodents and zebrafish in vivo, 2) decreased MPI correlates with advanced stages of liver fibrosis in human HBV and NAFLD cohorts, and 3) MPI depletion promotes HSC activation in human HSCs. Remarkably, mannose supplementation attenuates HSC activation in a dose-dependent manner. Our objective is to understand the regulatory role of mannose metabolism in HSCs and liver fibrosis. With the following aims, we will test our central hypotheses that mannose metabolism is a critical metabolic pathway mediating HSC activation and attenuation. Disruption of mannose metabolism, through loss of MPI, leads to HSC activation; conversely, exogeneous mannose supplementation can attenuate HSC activation and liver fibrosis in vivo. Specific Aims: Aim 1. Determine how MPI loss activates HSCs: By using primary rat HSCs and in vivo genetic zebrafish models, we will investigate the role of O-GlcNAcylation in HSC activation, determine the cell-specific effects of MPI-depletion, and test whether enhancing MPI activity can attenuate fibrogenesis following exposure to well-established HSC activators. Aim 2. Determine the efficacy of mannose supplementation in attenuating HSC activation in vitro and in vivo. This aim will use in vivo rodent models of fibrosis to investigate how mannose supplementation modulates the plasticity of HSC phenotypes and test the extent of mannose to attenuate liver fibrosis in vivo. Our long-term goal is to better understand the metabolic drivers of HSC activation to manipulate these fuel-generating mechanisms and attenuate liver fibrosis. We will leverage our expertise in the biology of a rare liver disease to advance our understanding of the metabolic regulation of HSC activation, and to establish how this overlooked pathway of mannose metabolism can regulate HSC plasticity. These studies are the first to investigate the antifibrotic roles of mannose supplementation and may reveal a novel target and accessible therapeutic approach to suppress liver fibrosis.

项目总结